Nat2 (n Acetyltransferase 2) - Toxicology

Relevant Publications

Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicity.

Issue Release: 2024

Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review.

Issue Release: 2024

Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis.

Issue Release: 2024

Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosis.

Issue Release: 2024

Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations.

Issue Release: 2024

Spermidine mediates acetylhypusination of RIPK1 to suppress diabetes onset and progression.

Issue Release: 2024

Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling.

Issue Release: 2024

Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis.

Issue Release: 2024

N-Acetyltransferase 2 gene polymorphism and its serum levels in vitiligo patients.

Issue Release: 2024

Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis.

Issue Release: 2024

A study of N-acetyltransferase 2 gene polymorphisms in the Indian population and its relationship with serum isoniazid concentrations in a cohort of tuberculosis patients.

Issue Release: 2024

Effect of N-acetyltransferase 2 genetic polymorphism on 4,4\'-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stress.

Issue Release: 2023

Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation.

Issue Release: 2023

Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database.

Issue Release: 2023

Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in ethiopian tuberculosis patients.

Issue Release: 2023

Application of a physiologically based pharmacokinetic model to predict isoniazid disposition during pregnancy.

Issue Release: 2023

N-acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer.

Issue Release: 2023

Induction of Glucose Production by Heterocyclic Amines is Dependent on N-acetyltransferase 2 Genetic Polymorphism in Cryopreserved Human Hepatocytes.

Issue Release: 2023

NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review.

Issue Release: 2023

Non-coding and intergenic genetic variants of human arylamine -acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders.

Issue Release: 2023

What is Liner in Toxicology?

How Can Skin Rashes from Toxic Exposure Be Prevented?

What is BPDE?

What are Chlorinated By-products?

How is Galactosemia Related to Toxicology?

What is Plutonium?

How are Pollutants Identified in Toxicology?

Can Multicollinearity Be Useful in Toxicology?

What are the Benefits of Using GWAS in Toxicology?

What Are the Implications of Off-Target Effects?

Partnered Content Networks

Relevant Topics